Stay updated on Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial page.

Latest updates to the Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial page
- Check3 days agoChange DetectedThe clinical trial record for a study of dapagliflozin plus pioglitazone in patients with HFpEF is displayed, with details about its design, participants, locations, and outcomes.SummaryDifference48%

- Check10 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0, while the study record still displays a 403 error.SummaryDifference0.2%

- Check17 days agoChange DetectedA site-wide banner announces NIH updates about replacing the term “Artificial Intelligence” with “Super Intelligence” during a transition.SummaryDifference1%

- Check24 days agoChange DetectedThe footer’s site revision number changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check31 days agoChange DetectedThe site footer revision number changes from v3.7.0 to v3.7.1. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now renders a 403 Forbidden error, replacing the study record details. The new view shows a minimal error page with a 403 message instead of the previously visible trial information.SummaryDifference18%

Stay in the know with updates to Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial page.